Generic placeholder image

Current Pharmaceutical Biotechnology

Editor-in-Chief

ISSN (Print): 1389-2010
ISSN (Online): 1873-4316

Challenges in Managing Amniotic Fluid Embolism: An Up-to-Date Perspective on Diagnostic Testing with Focus on Novel Biomarkers and Avenues for Future Research

Author(s): Stanislaw P. Stawicki and Thomas J. Papadimos

Volume 14, Issue 14, 2013

Page: [1168 - 1178] Pages: 11

DOI: 10.2174/1389201015666140430163921

Price: $65

Abstract

Amniotic fluid embolism (AFE) continues to pose a formidable clinical challenge with its high rate of morbidity and mortality. A novel biomarker that acts as an early warning system for the clinician would be a welcomed addition to our medical armamentarium. Here we review the state of diagnosing AFE with our current methods of evaluation and testing along with recently discovered potential biomarkers that may be clinically efficacious. Additionally we explore the future of proteomics, lipidomics, and transcriptomics as tools to identify potential novel signaling pathways and biomarkers.

Keywords: Amniotic fluid embolism, biomarkers, diagnosis, management, proteomics, transcriptomics.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy